Psychiatric Times·4 min read·hard
Balancing Efficacy, Tolerability, and Drug Monitoring in Schizophrenia Treatment
G
Gustavo Alva, MD, DFAPA, Hara Oyedeji, DNP, PMHNP-BC, Mark Jankelow, MSN, PMHNP-BC, Christoph U. Correll, MD, John M. Kane, MD
✦AI Summary
Experts Dr. John Kane and Dr. Christoph Correll discuss the necessity of therapeutic drug monitoring and the balance between efficacy and tolerability in schizophrenia treatment. They argue for personalized treatment goals and the use of reliable delivery systems like injectables.
In "Balancing Efficacy, Tolerability, and Drug Monitoring in Schizophrenia Treatment," our panel explores two interconnected clinical priorities: the underutilization of therapeutic drug monitoring and the need to reframe how clinicians weigh efficacy against tolerability over the long term.
health
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in